Browse by CSHL Author
- CSHL_Authors_List (9)
- Nandi, Saikat (9)
Paper
Rahman, M.A., Nasrin, F., Bhattacharjee, S., Nandi, S. (May 2020) Hallmarks of Splicing Defects in Cancer: Clinical Applications in the Era of Personalized Medicine. Cancers (Basel), 12 (6). E1381. ISSN 2072-6694
Huilgol, D., Venkataramani, P., Nandi, S., Bhattacharjee, S. (October 2019) Transcription Factors That Govern Development and Disease: An Achilles Heel in Cancer. Genes (Basel), 10 (10). ISSN 2073-4425
Ghosh, D., Venkataramani, P., Nandi, S., Bhattacharjee, S. (January 2019) CRISPR-Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics. Cancer Cell Int, 19. p. 12. ISSN 1475-2867 (Print)1475-2867
Ghosh, D., Nandi, S., Bhattacharjee, S. (October 2018) Combination therapy to checkmate Glioblastoma: clinical challenges and advances. Clin Transl Med, 7 (1). p. 33. ISSN 2001-1326 (Print)
Bhattacharjee, S., Nandi, S. (September 2018) Rare Genetic Diseases with Defects in DNA Repair: Opportunities and Challenges in Orphan Drug Development for Targeted Cancer Therapy. Cancers (Basel), 10 (9). ISSN 2072-6694 (Print)2072-6694
Bhattacharjee, S., Nandi, S. (December 2017) Synthetic lethality in DNA repair network: A novel avenue in targeted cancer therapy and combination therapeutics. IUBMB Life, 69 (12). pp. 929-937. ISSN 1521-6543
Bhattacharjee, S., Nandi, S. (October 2017) DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway. Cell Commun Signal, 15 (1). p. 41. ISSN 1478-811x
Yuan, Z., Riera, A., Bai, L., Sun, J., Nandi, S., Spanos, C., Chen, Z. A., Barbon, M., Rappsilber, J., Stillman, B., Speck, C., Li, H. (March 2017) Structural basis of Mcm2-7 replicative helicase loading by ORC-Cdc6 and Cdt1. Nat Struct Mol Biol, 24 (3). pp. 316-324. ISSN 1545-9985 (Public Dataset)
Bhattacharjee, S., Nandi, S. (December 2016) Choices have consequences: the nexus between DNA repair pathways and genomic instability in cancer. Clin Transl Med, 5 (1). p. 45. ISSN 2001-1326